Pfizer-Allergan Deal Off Following New Tax Regulations Targeting Inversions
The decision is a win for the Obama administration, which on Monday introduced the initiatives in an effort to foil companies' plans to shed their U.S. corporate citizenship for a lower tax bill.
The Wall Street Journal:
Pfizer To Walk Away From Allergan Deal
The New York Times:
Pfizer And Allergan Are Said To End Merger As Tax Rules Tighten
The Associated Press:
Analysts: New Inversion Rules Will Kill Pfizer-Allergan Deal
Reuters:
Obama's Inversion Curbs Kill Pfizer's Allergan Deal
The Wall Street Journal:
Allergan’s Inversion Problem: There Is A Plan B